Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Renalytix AI ( (GB:RENX) ) has issued an announcement.
Renalytix PLC announced a significant change in its shareholder structure as UBS Group AG, through its Investment Bank & Global Wealth Management, has reduced its holdings in the company to below 5%. This reduction in UBS’s trading book holdings means they are now exempt from reporting their stake in Renalytix PLC, highlighting a notable shift in investor interests and potential impacts on the company’s market perception.
More about Renalytix AI
YTD Price Performance: 0%
Average Trading Volume: 1,400
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $46.38M
For an in-depth examination of RENX stock, go to TipRanks’ Stock Analysis page.
